| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Art with guts
|
Smith, Oliver
|
|
2016
|
1 |
3 |
p. 182-183
2 p.
|
artikel
|
| 2 |
Correction
|
|
|
2016
|
1 |
3 |
p. e2-
1 p.
|
artikel
|
| 3 |
Correction
|
|
|
2016
|
1 |
3 |
p. e2-
1 p.
|
artikel
|
| 4 |
Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study
|
Bernal, William
|
|
2016
|
1 |
3 |
p. 217-225
9 p.
|
artikel
|
| 5 |
Dynamic outcome prediction for paracetamol-related acute liver failure
|
Ichai, Philippe
|
|
2016
|
1 |
3 |
p. 177-178
2 p.
|
artikel
|
| 6 |
Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments
|
Wait, Suzanne
|
|
2016
|
1 |
3 |
p. 248-255
8 p.
|
artikel
|
| 7 |
Microbes and the gut–brain axis
|
Wayman, Christina
|
|
2016
|
1 |
3 |
p. 183-
1 p.
|
artikel
|
| 8 |
POLE mutations in colorectal cancer: a new biomarker?
|
Eng, Cathy
|
|
2016
|
1 |
3 |
p. 176-177
2 p.
|
artikel
|
| 9 |
Reducing the effects of IBS on life
|
Wilsher, Matthew
|
|
2016
|
1 |
3 |
p. 184-
1 p.
|
artikel
|
| 10 |
Research in brief
|
Baker, Holly
|
|
2016
|
1 |
3 |
p. 180-
1 p.
|
artikel
|
| 11 |
Screening for liver fibrosis in the general population: a call for action
|
Ginès, Pere
|
|
2016
|
1 |
3 |
p. 256-260
5 p.
|
artikel
|
| 12 |
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
|
Domingo, Enric
|
|
2016
|
1 |
3 |
p. 207-216
10 p.
|
artikel
|
| 13 |
Tenofovir alafenamide for hepatitis B: evolution or revolution?
|
Brouwer, Willem P
|
|
2016
|
1 |
3 |
p. 174-175
2 p.
|
artikel
|
| 14 |
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
|
Chan, Henry L Y
|
|
2016
|
1 |
3 |
p. 185-195
11 p.
|
artikel
|
| 15 |
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
|
Buti, Maria
|
|
2016
|
1 |
3 |
p. 196-206
11 p.
|
artikel
|
| 16 |
The challenge of antimicrobial resistance
|
The Lancet Gastroenterology & Hepatology,
|
|
2016
|
1 |
3 |
p. 173-
1 p.
|
artikel
|
| 17 |
The 2016 Lasker-DeBakey Clinical Medical Research Award
|
Burki, Talha Khan
|
|
2016
|
1 |
3 |
p. 179-
1 p.
|
artikel
|
| 18 |
The liver transplant: “a tricky, tricky thing”
|
Mohammadi, Dara
|
|
2016
|
1 |
3 |
p. 181-
1 p.
|
artikel
|
| 19 |
The mesentery: structure, function, and role in disease
|
Coffey, J Calvin
|
|
2016
|
1 |
3 |
p. 238-247
10 p.
|
artikel
|
| 20 |
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
|
Hart, Phil A
|
|
2016
|
1 |
3 |
p. 226-237
12 p.
|
artikel
|
Tijdschrift beschrijving